Log in

NASDAQ:SVASinovac Biotech News Headlines

$6.47
0.00 (0.00 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$6.47
Now: $6.47
$6.47
50-Day Range
$6.47
MA: $6.47
$6.47
52-Week Range
$5.73
Now: $6.47
$8.75
VolumeN/A
Average VolumeN/A
Market Capitalization$639.88 million
P/E Ratio17.03
Dividend YieldN/A
Beta0.13

Headlines

Sinovac Biotech (NASDAQ SVA) News Headlines

Source:
DateHeadline
Sinovac secures $15M funding in the form of convertible loanSinovac secures $15M funding in the form of convertible loan
seekingalpha.com - May 22 at 1:00 PM
Sinovac Secures $15 Million in Funding to Accelerate COVID-19 Vaccine DevelopmentSinovac Secures $15 Million in Funding to Accelerate COVID-19 Vaccine Development
www.businesswire.com - May 22 at 1:00 PM
Sinovac Comments on SEC Findings Against Jiaqiang "Chiang" Li and 1Globe CapitalSinovac Comments on SEC Findings Against Jiaqiang "Chiang" Li and 1Globe Capital
www.businesswire.com - May 19 at 1:16 AM
SEC Finds Activist Investor Li Didnt Disclose Key Facts On Holdings Of SinovacSEC Finds Activist Investor Li Didn't Disclose Key Facts On Holdings Of Sinovac
www.nasdaq.com - May 18 at 9:43 AM
Sinovac Comments on SEC Findings Against Jiaqiang "Chiang" Li and 1Globe CapitalSinovac Comments on SEC Findings Against Jiaqiang "Chiang" Li and 1Globe Capital
finance.yahoo.com - May 18 at 9:43 AM
Sinovac COVID-19 vaccine shows positive effect in preclinical studySinovac COVID-19 vaccine shows positive effect in preclinical study
seekingalpha.com - May 6 at 12:48 PM
Sinovac Announces First Animal Study Results of Vaccine Against COVID-19 Published in SCIENCESinovac Announces First Animal Study Results of Vaccine Against COVID-19 Published in SCIENCE
finance.yahoo.com - May 6 at 12:48 PM
Sinovac Reports Unaudited Fourth Quarter 2019 Financial Results and Files 2019 Annual Report on Form 20-FSinovac Reports Unaudited Fourth Quarter 2019 Financial Results and Files 2019 Annual Report on Form 20-F
finance.yahoo.com - April 30 at 8:47 PM
China's Sinovac gains land and loans to speed up work on coronavirus vaccineChina's Sinovac gains land and loans to speed up work on coronavirus vaccine
finance.yahoo.com - April 23 at 9:44 AM
Sinovac launches early-stage study of COVID-19 vaccineSinovac launches early-stage study of COVID-19 vaccine
seekingalpha.com - April 17 at 8:50 AM
Sinovac Announces Commencement of Phase I Human Clinical Trial for Vaccine Candidate Against COVID-19Sinovac Announces Commencement of Phase I Human Clinical Trial for Vaccine Candidate Against COVID-19
finance.yahoo.com - April 17 at 8:50 AM
Dynavax teams up with Sinovac Biotech to develop COVID-19 vaccineDynavax teams up with Sinovac Biotech to develop COVID-19 vaccine
seekingalpha.com - April 16 at 8:53 AM
Sinovac Announces Approval of Human Clinical Trial for a Vaccine Candidate Against COVID-19Sinovac Announces Approval of Human Clinical Trial for a Vaccine Candidate Against COVID-19
finance.yahoo.com - April 14 at 9:06 PM
Sinovac Amends Shareholder Rights PlanSinovac Amends Shareholder Rights Plan
finance.yahoo.com - February 21 at 7:06 PM
Sinovac Biotechs chicken pox vaccine gets approval in ChinaSinovac Biotech's chicken pox vaccine gets approval in China
seekingalpha.com - December 27 at 1:47 PM
Sinovac Announces Approval of Varicella Vaccine for Prevention of Varicella-Zoster Virus (Chickenpox) in ChildrenSinovac Announces Approval of Varicella Vaccine for Prevention of Varicella-Zoster Virus (Chickenpox) in Children
finance.yahoo.com - December 27 at 1:47 PM
Sinovac Biotech Ltd. Stock Downgraded (SVA)Sinovac Biotech Ltd. Stock Downgraded (SVA)
www.thestreet.com - October 23 at 1:23 PM
Sinovac Reports Unaudited Second Quarter 2019 Financial ResultsSinovac Reports Unaudited Second Quarter 2019 Financial Results
finance.yahoo.com - August 15 at 6:02 PM
Sinovac Reports Unaudited First Quarter 2019 Financial ResultsSinovac Reports Unaudited First Quarter 2019 Financial Results
finance.yahoo.com - July 10 at 5:31 PM
Sinovac Reports Unaudited Second Half of 2018 Financial Results and Files 2018 Annual Report on Form 20-FSinovac Reports Unaudited Second Half of 2018 Financial Results and Files 2018 Annual Report on Form 20-F
finance.yahoo.com - April 29 at 5:45 PM
Sinovacs sIPV shows positive data in late-stage polio studySinovac's sIPV shows positive data in late-stage polio study
seekingalpha.com - April 16 at 10:18 AM
Sinovac Announces Positive Results From Phase III Trial Of a Sabin Strain-Based Inactivated Polio Vaccine (sIPV) Published in the Journal of Infectious DiseaseSinovac Announces Positive Results From Phase III Trial Of a Sabin Strain-Based Inactivated Polio Vaccine (sIPV) Published in the Journal of Infectious Disease
finance.yahoo.com - April 16 at 10:18 AM
Sinovac Update on the Exchange of Rights for Common and Series B Preferred SharesSinovac Update on the Exchange of Rights for Common and Series B Preferred Shares
finance.yahoo.com - March 9 at 9:33 AM
Nasdaq Halts Sinovac Biotech Ltd.Nasdaq Halts Sinovac Biotech Ltd.
finance.yahoo.com - February 22 at 5:58 PM
Sinovac Biotech activates poison pill defense in rare moveSinovac Biotech activates 'poison pill' defense in rare move
finance.yahoo.com - February 22 at 5:58 PM
Sinovac Determines Trigger Event Occurred Under Rights AgreementSinovac Determines Trigger Event Occurred Under Rights Agreement
finance.yahoo.com - February 22 at 5:58 PM
Can Sinovac Biotech Ltd.’s (NASDAQ:SVA) ROE Continue To Surpass The Industry Average?Can Sinovac Biotech Ltd.’s (NASDAQ:SVA) ROE Continue To Surpass The Industry Average?
finance.yahoo.com - January 4 at 4:56 PM
This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.